BMO downgrades Biogen, asserts company is spending too much on controversial Alzheimer's drug

  • 📰 CNBC
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 72%

España Noticias Noticias

España Últimas Noticias,España Titulares

Biogen's new Alzheimer's drug aduhelm saw limited pickup in its first few months on the market.

 

Gracias por tu comentario. Tu comentario será publicado después de ser revisado.

No wonder….

For all those who are new to this working from home Bitcoin trading options Here's a little tip: Get a trusted Bitcoin expert and stick to him Neal_48 Invest and play at similar times each day. Because : In times of chaos, your investment is your anchor to success

$SAVA coming soon to offer competition

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

 /  🏆 12. in ES

España Últimas Noticias, España Titulares